acetylsalicylic acid, caffeine and 8 mg codeine phosphate tablet
cellchem pharmaceuticals inc. - acetylsalicylic acid; caffeine; codeine phosphate - tablet - 375mg; 15mg; 8mg - acetylsalicylic acid 375mg; caffeine 15mg; codeine phosphate 8mg - opiate agonists
acetylsalicylic acid, caffeine & 8 mg codeine phosphate tablets
jamp pharma corporation - acetylsalicylic acid; caffeine; codeine phosphate - tablet - 375mg; 15mg; 8mg - acetylsalicylic acid 375mg; caffeine 15mg; codeine phosphate 8mg - opiate agonists
acetylsalicylic acid caffeine & 8mg cod phos tablet
stanley pharmaceuticals, a division of vita health products inc. - codeine (codeine phosphate); acetylsalicylic acid; caffeine - tablet - 8mg; 375mg; 15mg - codeine (codeine phosphate) 8mg; acetylsalicylic acid 375mg; caffeine 15mg - salicylates
asa, caffeine & 8mg codeine phosphate tablet
canapharm manufacturing inc - acetylsalicylic acid; caffeine; codeine phosphate - tablet - 325mg; 15mg; 8mg - acetylsalicylic acid 325mg; caffeine 15mg; codeine phosphate 8mg - salicylates
solpadeine soluble tablets paracetamol 500mg codeine phosphate hemihydrate 8mg caffeine 30mg
chefaro ireland dac the sharp building, hogan place, dublin 2,, ireland - codeine phosphate, hemihydrate, caffeine, paracetamol - effervescent tablet - codeine phosphate hemihydrate 8 mg caffeine 30 mg paracetamol 500 mg - analgesics
butalbital, aspirin, caffeine and codeine phosphate capsule
actavis pharma, inc. - codeine phosphate (unii: gsl05y1mn6) (codeine anhydrous - unii:ux6owy2v7j), butalbital (unii: khs0az4jvk) (butalbital - unii:khs0az4jvk), caffeine (unii: 3g6a5w338e) (caffeine - unii:3g6a5w338e), aspirin (unii: r16co5y76e) (aspirin - unii:r16co5y76e) - codeine phosphate 30 mg - butalbital, aspirin, caffeine, and codeine phosphate capsules, usp are indicated for the management of the symptom complex of tension (or muscle contraction) headache, when non-opioid analgesic and alternative treatments are inadequate. limitations of use : because of the risks of addiction, abuse, and misuse with opioids and butalbital, even at recommended doses [see warnings and precautions ( 5.1 )] , reserve butalbital, aspirin, caffeine, and codeine phosphate capsules, usp for use in patients for whom alternative treatment options (e.g., non-opioid, non-barbiturate analgesics): - have not been tolerated, or are not expected to be tolerated, - have not provided adequate analgesia, or are not expected to provide adequate analgesia butalbital, aspirin, caffeine, and codeine phosphate capsules, usp are contraindicated for: - all children younger than 12 years of age [see warnings and precautions ( 5.5 )] - postoperative management in children younger than 18 years of age following tonsillectomy and/or adeno
promethazine hydrochloride and codeine phosphate solution
akorn - codeine phosphate (unii: gsl05y1mn6) (codeine anhydrous - unii:ux6owy2v7j), promethazine hydrochloride (unii: r61zeh7i1i) (promethazine - unii:ff28ejq494) - codeine phosphate 10 mg in 5 ml - promethazine hcl and codeine phosphate oral solution is indicated for the temporary relief of coughs and upper respiratory symptoms associated with allergy or the common cold in patients 18 years of age and older. important limitations of use: promethazine hcl and codeine phosphate oral solution is contraindicated for: promethazine hcl and codeine phosphate oral solution is also contraindicated in patients with: risk summary promethazine hcl and codeine phosphate oral solution is not recommended for use in pregnant women, including during or immediately prior to labor. prolonged use of opioids during pregnancy may cause neonatal opioid withdrawal syndrome [see warnings and precautions (5.19), clinical considerations ]. there are no available data with promethazine hcl and codeine phosphate oral solution use in pregnant women to inform a drug-associated risk for adverse developmental outcomes. published studies with codeine have reported inconsistent findings and have important methodological limitations (see
paracetamol/codeine gh 500/30 paracetamol 500 mg and codeine phosphate hemihydrate 30 mg tablet blister pack
sanofi-aventis australia pty ltd - paracetamol, quantity: 500 mg; codeine phosphate hemihydrate, quantity: 30 mg - tablet, uncoated - excipient ingredients: potassium sorbate; maize starch; povidone; purified talc; stearic acid; magnesium stearate; microcrystalline cellulose; croscarmellose sodium; pregelatinised maize starch - paracetamol/codeine gh 500/30 is indicated for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.
c t acetylsalicylic acid codeine and caf tab tablet
pharmavite laboratories (1987) inc. - acetylsalicylic acid; caffeine; codeine phosphate - tablet - 325mg; 16mg; 8mg - acetylsalicylic acid 325mg; caffeine 16mg; codeine phosphate 8mg - salicylates
asa-caffeine-codeine tablet
laboratoires confab inc - acetylsalicylic acid; caffeine; codeine phosphate - tablet - 375mg; 15mg; 8mg - acetylsalicylic acid 375mg; caffeine 15mg; codeine phosphate 8mg - salicylates